Logo image of MAPS.MI

MAPS SPA (MAPS.MI) Stock Fundamental Analysis

BIT:MAPS - Euronext Milan - IT0005364333 - Common Stock - Currency: EUR

3  +0.01 (+0.33%)

Fundamental Rating

5

Taking everything into account, MAPS scores 5 out of 10 in our fundamental rating. MAPS was compared to 101 industry peers in the Software industry. MAPS has an average financial health and profitability rating. MAPS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MAPS had positive earnings in the past year.
In the past year MAPS had a positive cash flow from operations.
Each year in the past 5 years MAPS has been profitable.
MAPS had a positive operating cash flow in each of the past 5 years.
MAPS.MI Yearly Net Income VS EBIT VS OCF VS FCFMAPS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

MAPS's Return On Assets of 2.04% is in line compared to the rest of the industry. MAPS outperforms 51.52% of its industry peers.
MAPS has a Return On Equity (4.65%) which is in line with its industry peers.
MAPS has a Return On Invested Capital of 4.16%. This is comparable to the rest of the industry: MAPS outperforms 56.57% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MAPS is significantly below the industry average of 11.53%.
The 3 year average ROIC (4.09%) for MAPS is below the current ROIC(4.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.04%
ROE 4.65%
ROIC 4.16%
ROA(3y)3.98%
ROA(5y)4.51%
ROE(3y)10.31%
ROE(5y)12.23%
ROIC(3y)4.09%
ROIC(5y)4.44%
MAPS.MI Yearly ROA, ROE, ROICMAPS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

MAPS's Profit Margin of 3.76% is in line compared to the rest of the industry. MAPS outperforms 51.52% of its industry peers.
In the last couple of years the Profit Margin of MAPS has declined.
The Operating Margin of MAPS (7.42%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MAPS has declined.
Looking at the Gross Margin, with a value of 77.62%, MAPS is in the better half of the industry, outperforming 65.66% of the companies in the same industry.
MAPS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.42%
PM (TTM) 3.76%
GM 77.62%
OM growth 3Y0.55%
OM growth 5Y-21.96%
PM growth 3Y-17.8%
PM growth 5Y-23.32%
GM growth 3Y3.67%
GM growth 5Y-1.28%
MAPS.MI Yearly Profit, Operating, Gross MarginsMAPS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAPS is destroying value.
MAPS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MAPS has more shares outstanding
The debt/assets ratio for MAPS has been reduced compared to a year ago.
MAPS.MI Yearly Shares OutstandingMAPS.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
MAPS.MI Yearly Total Debt VS Total AssetsMAPS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.00 indicates that MAPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
MAPS has a Altman-Z score (2.00) which is in line with its industry peers.
The Debt to FCF ratio of MAPS is 5.18, which is a neutral value as it means it would take MAPS, 5.18 years of fcf income to pay off all of its debts.
MAPS has a Debt to FCF ratio (5.18) which is in line with its industry peers.
A Debt/Equity ratio of 0.38 indicates that MAPS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.38, MAPS is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.18
Altman-Z 2
ROIC/WACC0.5
WACC8.38%
MAPS.MI Yearly LT Debt VS Equity VS FCFMAPS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

MAPS has a Current Ratio of 1.86. This is a normal value and indicates that MAPS is financially healthy and should not expect problems in meeting its short term obligations.
MAPS has a better Current ratio (1.86) than 70.71% of its industry peers.
A Quick Ratio of 1.35 indicates that MAPS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.35, MAPS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.35
MAPS.MI Yearly Current Assets VS Current LiabilitesMAPS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The earnings per share for MAPS have decreased strongly by -28.85% in the last year.
The earnings per share for MAPS have been decreasing by -15.92% on average. This is quite bad
Looking at the last year, MAPS shows a small growth in Revenue. The Revenue has grown by 6.55% in the last year.
Measured over the past years, MAPS shows a quite strong growth in Revenue. The Revenue has been growing by 16.23% on average per year.
EPS 1Y (TTM)-28.85%
EPS 3Y-10.67%
EPS 5Y-15.92%
EPS Q2Q%53.25%
Revenue 1Y (TTM)6.55%
Revenue growth 3Y17.6%
Revenue growth 5Y16.23%
Sales Q2Q%-6.08%

3.2 Future

The Earnings Per Share is expected to grow by 54.46% on average over the next years. This is a very strong growth
Based on estimates for the next years, MAPS will show a quite strong growth in Revenue. The Revenue will grow by 12.97% on average per year.
EPS Next Y100%
EPS Next 2Y69.56%
EPS Next 3Y55.36%
EPS Next 5Y54.46%
Revenue Next Year12.55%
Revenue Next 2Y11.1%
Revenue Next 3Y11.44%
Revenue Next 5Y12.97%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MAPS.MI Yearly Revenue VS EstimatesMAPS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
MAPS.MI Yearly EPS VS EstimatesMAPS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.33, the valuation of MAPS can be described as expensive.
Based on the Price/Earnings ratio, MAPS is valued a bit cheaper than 69.70% of the companies in the same industry.
MAPS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
MAPS is valuated correctly with a Price/Forward Earnings ratio of 12.79.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MAPS indicates a rather cheap valuation: MAPS is cheaper than 90.91% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MAPS to the average of the S&P500 Index (22.10), we can say MAPS is valued slightly cheaper.
Industry RankSector Rank
PE 33.33
Fwd PE 12.79
MAPS.MI Price Earnings VS Forward Price EarningsMAPS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

86.87% of the companies in the same industry are more expensive than MAPS, based on the Enterprise Value to EBITDA ratio.
86.87% of the companies in the same industry are more expensive than MAPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.16
EV/EBITDA 7.91
MAPS.MI Per share dataMAPS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MAPS's earnings are expected to grow with 55.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y69.56%
EPS Next 3Y55.36%

0

5. Dividend

5.1 Amount

No dividends for MAPS!.
Industry RankSector Rank
Dividend Yield N/A

MAPS SPA

BIT:MAPS (3/5/2025, 7:00:00 PM)

3

+0.01 (+0.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.99%
Inst Owner ChangeN/A
Ins Owners50.83%
Ins Owner ChangeN/A
Market Cap39.84M
Analysts85
Price Target4.91 (63.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 33.33
Fwd PE 12.79
P/S 1.31
P/FCF 13.16
P/OCF 5.94
P/B 1.62
P/tB N/A
EV/EBITDA 7.91
EPS(TTM)0.09
EY3%
EPS(NY)0.23
Fwd EY7.82%
FCF(TTM)0.23
FCFY7.6%
OCF(TTM)0.5
OCFY16.82%
SpS2.29
BVpS1.85
TBVpS-0.06
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 4.65%
ROCE 5.54%
ROIC 4.16%
ROICexc 5.14%
ROICexgc 22.35%
OM 7.42%
PM (TTM) 3.76%
GM 77.62%
FCFM 9.94%
ROA(3y)3.98%
ROA(5y)4.51%
ROE(3y)10.31%
ROE(5y)12.23%
ROIC(3y)4.09%
ROIC(5y)4.44%
ROICexc(3y)5.3%
ROICexc(5y)5.7%
ROICexgc(3y)16.62%
ROICexgc(5y)15.52%
ROCE(3y)5.46%
ROCE(5y)5.92%
ROICexcg growth 3Y8.08%
ROICexcg growth 5Y-27.37%
ROICexc growth 3Y-2.31%
ROICexc growth 5Y-29.52%
OM growth 3Y0.55%
OM growth 5Y-21.96%
PM growth 3Y-17.8%
PM growth 5Y-23.32%
GM growth 3Y3.67%
GM growth 5Y-1.28%
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 5.18
Debt/EBITDA 1.58
Cap/Depr 99.79%
Cap/Sales 12.07%
Interest Coverage 250
Cash Conversion 112.75%
Profit Quality 264.63%
Current Ratio 1.86
Quick Ratio 1.35
Altman-Z 2
F-Score6
WACC8.38%
ROIC/WACC0.5
Cap/Depr(3y)249.96%
Cap/Depr(5y)281.79%
Cap/Sales(3y)26.2%
Cap/Sales(5y)30.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.85%
EPS 3Y-10.67%
EPS 5Y-15.92%
EPS Q2Q%53.25%
EPS Next Y100%
EPS Next 2Y69.56%
EPS Next 3Y55.36%
EPS Next 5Y54.46%
Revenue 1Y (TTM)6.55%
Revenue growth 3Y17.6%
Revenue growth 5Y16.23%
Sales Q2Q%-6.08%
Revenue Next Year12.55%
Revenue Next 2Y11.1%
Revenue Next 3Y11.44%
Revenue Next 5Y12.97%
EBIT growth 1Y29.59%
EBIT growth 3Y18.25%
EBIT growth 5Y-9.3%
EBIT Next Year315.05%
EBIT Next 3Y83.43%
EBIT Next 5Y66.96%
FCF growth 1Y149.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y396.85%
OCF growth 3Y8.27%
OCF growth 5Y22.5%